(Q44794199)

6 December 2017

Impact of pneumococcal vaccination in Denmark during the first 3 years after PCV introduction in the childhood immunization programme (English)

1 reference

6 December 2017

0 references

0 references

Palle Valentiner-Branth

8

object named as

Palle Valentiner-Branth

1 reference

6 December 2017

Lotte Munch Lambertsen

object named as

Lotte Lambertsen

9

0 references

author name string

Helene Ingels

1

1 reference

6 December 2017

Jeppe Rasmussen

2

1 reference

6 December 2017

Peter Henrik Andersen

3

1 reference

6 December 2017

Zitta B Harboe

4

1 reference

6 December 2017

Steffen Glismann

5

1 reference

6 December 2017

Helle Konradsen

6

1 reference

6 December 2017

Steen Hoffmann

7

1 reference

6 December 2017

Danish Pneumococcal Surveillance Collaboration Group 2009-2010

10

1 reference

6 December 2017

language of work or name

English

0 references

publication date

11 April 2012

1 reference

6 December 2017

1 reference

6 December 2017

30

1 reference

6 December 2017

3944-3950

1 reference

6 December 2017

26

1 reference

Decline in Invasive Pneumococcal Disease after the Introduction of Protein–Polysaccharide Conjugate Vaccine

6 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.060

Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northern California Kaiser Permanente Vaccine Study Center Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.060

Immunogenicity of a Reduced Schedule of Pneumococcal Conjugate Vaccine in Healthy Infants and Correlates of Protection for Serotype 6B in the United Kingdom

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.060

Indirect effect of conjugate pneumococcal vaccination in a 2+1 dose schedule

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.060

Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.060

Decline in pneumonia admissions after routine childhood immunisation with pneumococcal conjugate vaccine in the USA: a time-series analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.060

Pneumococcal conjugate vaccination and nasopharyngeal acquisition of pneumococcal serotype 19A strains

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.060

Effect of seven-valent pneumococcal conjugate vaccine on Staphylococcus aureus colonisation in a randomised controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.060

Observed differences in invasive pneumococcal disease epidemiology after routine infant vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.060

Early effectiveness of heptavalent conjugate pneumococcal vaccination on invasive pneumococcal disease after the introduction in the Danish Childhood Immunization Programme

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.060

Temporal trends in invasive pneumococcal disease and pneumococcal serotypes over 7 decades

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.060

Uptake of the human papillomavirus-vaccination within the free-of-charge childhood vaccination programme in Denmark

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.060

Estimated effect of pneumococcal conjugate vaccination on invasive pneumococcal disease and associated mortality, Denmark 2000-2005.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.060

Pneumococcal serotypes and mortality following invasive pneumococcal disease: a population-based cohort study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.060

Association of serotype with risk of death due to pneumococcal pneumonia: a meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.060

Epidemiological differences among pneumococcal serotypes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.060

Incidence of pneumococcal disease due to non-pneumococcal conjugate vaccine (PCV7) serotypes in the United States during the era of widespread PCV7 vaccination, 1998-2004.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.060

Six newly recognized types of Streptococcus pneumoniae.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.03.060

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VACCINE.2012.03.060

1 reference

release_t7idkfns6nbjpgljlmdpfxcnb4

6 December 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/t7idkfns6nbjpgljlmdpfxcnb4

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference